Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (131-140 of 399) with videos related to

Pageof 40
Sort By:
Lancet (London, England)|March 21, 2006
Renoprotective effects of renin-angiotensin-system inhibitorsDick de Zeeuw, Edmund J Lewis, Giuseppe Remuzzi, et al.
Journal of the American Society of Nephrology : JASN|December 24, 2005
Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent mannerMarisa A Gallicchio, E Anne McRobert, Anjali Tikoo, et al.
Kidney International|May 11, 2005
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetesMerlin C Thomas, George Jerums, Con Tsalamandris, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Localization of the ezrin binding epitope for glycated proteinsE Anne McRobert, Anjali Tikoo, Marisa A Gallicchio, et al.
Diabetologia|May 19, 2022
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 dataJinli Liu, Ruhai Bai, Zhonglin Chai, et al.
Diabetes Care|May 29, 2002
Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restrictionChristine A Houlihan, Aysel Akdeniz, Con Tsalamandris, et al.
Diabetes Care|September 28, 2006
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetesWolfgang C Winkelmayer, Zhongxin Zhang, Shahnaz Shahinfar, et al.
Endocrine Connections|May 9, 2023
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative reviewMerlin C Thomas, Brendon L Neuen, Stephen M Twigg, et al.
Diabetes Care|June 6, 2025
Kidney Disease: The Forgotten Legacy of Type 1 DiabetesMerlin C Thomas, Sophia Zoungas, Nordin M J Hanssen, et al.
Diabetes|March 30, 2004
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF ratChristos Tikellis, Peter J Wookey, Riccardo Candido, et al.
Pageof 40

Showing results (131-140 of 399) with videos related to

Sort By:
Pageof 40
Lancet (London, England)|March 21, 2006
Renoprotective effects of renin-angiotensin-system inhibitorsDick de Zeeuw, Edmund J Lewis, Giuseppe Remuzzi, et al.
Journal of the American Society of Nephrology : JASN|December 24, 2005
Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent mannerMarisa A Gallicchio, E Anne McRobert, Anjali Tikoo, et al.
Kidney International|May 11, 2005
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetesMerlin C Thomas, George Jerums, Con Tsalamandris, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Localization of the ezrin binding epitope for glycated proteinsE Anne McRobert, Anjali Tikoo, Marisa A Gallicchio, et al.
Diabetologia|May 19, 2022
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 dataJinli Liu, Ruhai Bai, Zhonglin Chai, et al.
Diabetes Care|May 29, 2002
Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restrictionChristine A Houlihan, Aysel Akdeniz, Con Tsalamandris, et al.
Diabetes Care|September 28, 2006
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetesWolfgang C Winkelmayer, Zhongxin Zhang, Shahnaz Shahinfar, et al.
Endocrine Connections|May 9, 2023
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative reviewMerlin C Thomas, Brendon L Neuen, Stephen M Twigg, et al.
Diabetes Care|June 6, 2025
Kidney Disease: The Forgotten Legacy of Type 1 DiabetesMerlin C Thomas, Sophia Zoungas, Nordin M J Hanssen, et al.
Diabetes|March 30, 2004
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF ratChristos Tikellis, Peter J Wookey, Riccardo Candido, et al.
Pageof 40